Posted in | News | Business | Mining

World's Largest Steel Manufacturer to Acquire Canadian Iron Ore and Pellet Producer

ArcelorMittal today announces that it will acquire Wabush Mines, an iron ore and pellet producer in northeastern Canada.

The company will exercise the option ("right of first refusal") that its Dofasco subsidiary had on the Wabush Mines Joint Venture. Dofasco, which already held 28.6% of the mining venture, will acquire the interests of Stelco (44.6%) and Cleveland Cliffs (26.8%) on the same terms as those offered by Consolidated Thompson on June 6th, 2007. These terms include a cash element of around US$67 million and certain liabilities. As a result, ArcelorMittal will own 100% of the mining company. The transaction, which is subject to regulatory approval, is expected to be finalised by December 2007.

Wabush produces concentrates at its Scully mine in Wabush (Newfoundland & Labrador). The concentrate is transported by rail to its Pointe Noire pelletizing and port facility located on the north shore of the St. Lawrence River. Yearly production of pellets is approximately 4.8 million tonnes. Wabush's mine and port operations are close to those of QCM (Québec Cartier Mines), a mining subsidiary of Dofasco.

Malay Mukherjee, member of ArcelorMittal's Group Management Board in charge of Mining, said: "The acquisition of Wabush Mines and facilities will enable us to exploit the synergies with the Group's existing QCM operations to increase overall pellet production in the medium term by about 3.5 million tonnes per year. This will bring ArcelorMittal closer to its stated objective of 75% iron ore self-sufficiency".

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.